MR imaging and cholangiography show suboptimal performance for diagnosing ductal cholangiocarcinoma in primary sclerosing cholangitis patients
- PMID: 40285814
- DOI: 10.1007/s00330-025-11606-0
MR imaging and cholangiography show suboptimal performance for diagnosing ductal cholangiocarcinoma in primary sclerosing cholangitis patients
Abstract
Objectives: Our purpose was to evaluate the performance of MR imaging/cholangiography for ductal cholangiocarcinoma (CCA) diagnosis and to search for specific MR features of ductal CCA among primary sclerosing cholangitis (PSC) patients.
Methods: We retrospectively analyzed 31 patients from a single center, each with a diagnosis of PSC, and suspicion of ductal CCA. Ductal CCA had been suspected during multidisciplinary team meetings when high-grade biliary stenosis was associated with focal thickening of the biliary wall. Two radiologists blinded to clinical information and imaging history independently reviewed patients' MR examinations using a standardized model created for this study. Fisher's exact test and Student's t-test were used to analyze the population's characteristics. Fisher's exact test and the chi-square test were used to compare associations of categorical variables (each standard model's item) with the final diagnosis. Interobserver agreement was assessed by Cohen's κ coefficient.
Results: Our population had a mean age of 42.7 ± 13.6 years and included 68% males. The final diagnosis was ductal CCA for 14 patients, and inflammatory stenosis for 17 patients. For diagnosing CCA, MR imaging/cholangiography exhibited a sensitivity of 43-50% and specificity of 70-76%, with low positive predictive (58-60%) and negative predictive (62-63%) values. Interobserver agreement ranged from κ = 0.04-0.75. Univariate analysis revealed no significant association between individual MR imaging/cholangiography features and CCA diagnosis.
Conclusion: MR imaging/cholangiography showed suboptimal performance for ductal CCA diagnosis among PSC patients and we did not find any specific feature to distinguish ductal CCA from inflammatory stenosis.
Key points: Question Diagnosing ductal cholangiocarcinoma in patients with primary sclerosing cholangitis remains challenging without known predictive MR imaging features. Findings MR imaging/cholangiography exhibited low sensitivity, specificity, and interobserver reliability for ductal cholangiocarcinoma diagnosis in primary sclerosing cholangitis and lacks reliability for distinguishing between benign and malignant strictures. Clinical relevance Diagnosing ductal cholangiocarcinoma in patients with primary sclerosing cholangitis remains challenging and our retrospective study demonstrates that MR imaging lacks reliability in distinguishing between benign and malignant high-grade strictures and did not find any specific MR feature of ductal CCA.
Keywords: Cholangiocarcinoma; MR imaging; Primary sclerosing cholangitis.
© 2025. The Author(s), under exclusive licence to European Society of Radiology.
Conflict of interest statement
Compliance with ethical standards. Guarantor: The scientific guarantor of this publication is Lionel Arrivé. Conflict of interest: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. Statistics and biometry: One of the authors (Quentin Bui) has significant statistical expertise. Informed consent: Written informed consent was waived by the Institutional Review Board. Ethical approval: Institutional Review Board approval was obtained. Study subjects or cohorts overlap: No study subjects or cohorts have been previously reported. Methodology: Retrospective Observational
Comment in
-
Shading light in the black box of hepatobiliary imaging.Eur Radiol. 2025 Oct;35(10):6541-6543. doi: 10.1007/s00330-025-11740-9. Epub 2025 Jun 6. Eur Radiol. 2025. PMID: 40478349 No abstract available.
Similar articles
-
Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis.Gastrointest Endosc. 2014 May;79(5):783-9. doi: 10.1016/j.gie.2013.09.015. Epub 2013 Oct 18. Gastrointest Endosc. 2014. PMID: 24140129
-
Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis.Gastrointest Endosc. 2014 Jun;79(6):943-950.e3. doi: 10.1016/j.gie.2013.11.001. Epub 2013 Dec 19. Gastrointest Endosc. 2014. PMID: 24360654
-
Systematic review with meta-analysis: endoscopic retrograde cholangiopancreatography-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.Aliment Pharmacol Ther. 2016 Dec;44(11-12):1139-1151. doi: 10.1111/apt.13817. Epub 2016 Oct 3. Aliment Pharmacol Ther. 2016. PMID: 27696456
-
Integrating multi-omics in bile for biomarker discovery in cholangiocarcinoma.Hepatol Commun. 2025 Aug 26;9(9):e0786. doi: 10.1097/HC9.0000000000000786. eCollection 2025 Sep 1. Hepatol Commun. 2025. PMID: 40857390 Free PMC article.
-
Endoscopic retrograde cholangiopancreatography versus intraoperative cholangiography for diagnosis of common bile duct stones.Cochrane Database Syst Rev. 2015 Feb 26;2015(2):CD010339. doi: 10.1002/14651858.CD010339.pub2. Cochrane Database Syst Rev. 2015. PMID: 25719222 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical